Tag

Sonelokimab

All articles tagged with #sonelokimab

health25 days ago•2 min saved

MoonLake's nanobody delivers strong phase 3 results in psoriatic arthritis

MoonLake Immunotherapeutics reported positive topline phase 3 IZAR-1 data for biologic‑naïve psoriatic arthritis patients treated with sonelokimab, with week‑16 endpoints meeting across ACR50 (42.1%), ACR20 (66.5%), minimal disease activity (41.2%), and PASI90 in patients with skin involvement (61%), though there is no active comparator arm and topline results will be followed by blinded analyses with full data due in H1 2027; IZAR-2 and other IL-17 nanobody programs are ongoing.

via Fierce Biotech|

#health #moonlake-immunotherapeutics #nanobody

business11 months ago•1 min saved

MoonLake's Stock Plummets 89% Amid Autoimmune Drug Trial Failures

MoonLake Immunotherapeutics' stock plummeted over 88% after its skin disease treatment, sonelokimab, showed only mixed results in clinical trials for hidradenitis suppurativa, with only one of two studies meeting its goal and a higher-than-expected placebo response, leading to investor disappointment.

via Investor's Business Daily|

#business #hidradenitis-suppurativa #moonlake

business11 months ago•1 min saved

MoonLake's Autoimmune Drug Failure Causes Stock Collapse

MoonLake Immunotherapeutics reported failure in its Phase 3 trials for the autoimmune skin condition hidradenitis suppurativa, leading to a sharp decline in its stock price. Despite some statistical significance in one study, the drug sonelokimab did not meet the efficacy benchmarks required to compete with existing treatments, casting doubt on its commercial prospects.

via statnews.com|

#autoimmune-drug-failure #biotech-investment #business